[go: up one dir, main page]

KR950032205A - 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용 - Google Patents

5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용 Download PDF

Info

Publication number
KR950032205A
KR950032205A KR1019950011238A KR19950011238A KR950032205A KR 950032205 A KR950032205 A KR 950032205A KR 1019950011238 A KR1019950011238 A KR 1019950011238A KR 19950011238 A KR19950011238 A KR 19950011238A KR 950032205 A KR950032205 A KR 950032205A
Authority
KR
South Korea
Prior art keywords
group
dihydro
thieno
formula
straight
Prior art date
Application number
KR1019950011238A
Other languages
English (en)
Inventor
베도야 주리타 마누엘
안토니오 디아즈 마르틴 후안
델 솔 모레노 그레고리오
마르틴 에스쿠데로 페레즈 울피아노
돌로레스 지메네즈 바르궤노 마리아
로마나츠 페레르 마갈리
Original Assignee
에. 뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에. 뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에. 뚜레 레메뜨르
Publication of KR950032205A publication Critical patent/KR950032205A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

일반식(I)의 5,6-디히드로-4H-티에노[3,4-c]피롤 유도체와 제약적으로 허용되는 산과의 이것이 부가염
여기서, R1은 시아노기, C1-4알콕시기,C1-4알킬티오기, C1-4알칼술포닐기, 피리딜기, 3,4-디메톡시페닐기 또는 하나 또는 두개의 알킬로 임의로 치환된 시클로 프로필기를 나타내거나, 아니면 COR기(여기서, R은 C1-4알킬기, 페닐기 또는 피페리딜기이다.)를 나타내거나, 아니면 하나이상의 할로겐 원자 및/또는 직쇄 또는 분자쇄 C1-4알킬기, 직쇄 또는 분자쇄 C1-4알콕시기 또는 CO2R′기(여기서, R′은 직쇄 또는 분지쇄 C1-4알킬기이다.)로 치환된 벤질기를 나타내거나, 아니면 나프틸메틸기를 나타낸다. 치료에의 이용.

Description

5,6-디히드로-4H-티에노[3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 일반식(I)의 5,6-디히드로-4H-티에노[3,4-c] 피롤유도체와 제약적으로 허용되는 산과의 이것이 부가염.
    (여기서, R1은 시아노기, C1-4알콕시기, C1-4알킬티오기, C1-4알킬술포닐기, 피리딜기, 3,4-디메톡시페닐기 또는 하나 또는 두개의 알킬기로 임의로 치환된 시클로 프로필기를 나타내거나, 아니면 COR기(여기서, R은 C1-4알킬기, 페닐기 또는 피페리딜기이다.)를 나타내거나, 아니면 하나이상의 할로겐 원자 및/또는 직쇄 또는 분자쇄 C1-4알킬기, 직쇄 또는 분자쇄 C1-4알콕시기 또는 CO2R'기(여기서, R'은 직쇄 또는 분지쇄 C1-4알킬기이다.)로 치환된 벤질기를 나타내거나, 아니면 나프틸메틸기를 나타낸다.)
  2. 1-메톡시-5-[(4,5-디히드로-1H-이미다졸-2-일)메틸]-5,6-디히드로-4H-티에노[3,4-c]피롤 디히드로클로라이드.
  3. 1-메톡시-5-[(4,5-디히드로-1H-이미다졸-2-일)메틸]-5,6-디히드로-4H-티에노[3,4-c]피롤 디히드로클로라이드.
  4. 식(Ⅱ)
    (여기서, R1은 제1항에 정의되어 있다.)의 화합물 N,N-디이소프로필에틸아민의 존재에서 디메틸포름아미드 같은 용매중에서 2-클로로메틸-4,5-디히드로-1H-이미다졸과 반응시키는 것을 특징으로 하는 제1항에 따른 식(I)의 화합물의 제조방법.
  5. 제1항에 따른 식(I)의 화합물로 이루어진 것을 특징으로 하는 의약.
  6. 적당한 부형제와 조합하여 제1항에 따른 식(I)의 화합물을 함유하는 것을 특징으로 하는 제약조성물.
  7. 식(I)(여기서, R1은 C1-4알콕시기, 피리딜기 또는 3,4-디메톡시페닐기를 나타낸다.)의 화합물 제조를 위한 합성중간체로서의 1,1-디메틸에틸 1-보로노-5,6-디히드로-4H-티에노[3,4-c]피롤-5-카르복실레이트.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019950011238A 1994-05-10 1995-05-09 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용 KR950032205A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR94-05716 1994-05-10
FR9405716A FR2719844B1 (fr) 1994-05-10 1994-05-10 Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
KR950032205A true KR950032205A (ko) 1995-12-20

Family

ID=9463059

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950011238A KR950032205A (ko) 1994-05-10 1995-05-09 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용

Country Status (17)

Country Link
EP (1) EP0682028A1 (ko)
JP (1) JPH0853457A (ko)
KR (1) KR950032205A (ko)
CN (1) CN1117970A (ko)
AU (1) AU1793395A (ko)
CA (1) CA2148880A1 (ko)
CZ (1) CZ119695A3 (ko)
FI (1) FI952250L (ko)
FR (1) FR2719844B1 (ko)
HU (1) HUT72667A (ko)
IL (1) IL113673A0 (ko)
NO (1) NO951812L (ko)
NZ (1) NZ272090A (ko)
PL (1) PL308516A1 (ko)
RU (1) RU95107154A (ko)
SK (1) SK59795A3 (ko)
ZA (1) ZA953749B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
FR2733750B1 (fr) * 1995-05-03 1997-06-13 Synthelabo Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
CA2327543A1 (en) 1998-05-06 1999-11-11 Duke University Method of treating bladder and lower urinary tract syndromes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8529546D0 (en) * 1985-11-30 1986-01-08 Beecham Group Plc Compounds
JPH06510760A (ja) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー 代謝障害および代謝の治療法
EP0599697A1 (fr) * 1992-11-24 1994-06-01 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique

Also Published As

Publication number Publication date
HUT72667A (en) 1996-05-28
JPH0853457A (ja) 1996-02-27
FI952250L (fi) 1995-11-11
IL113673A0 (en) 1995-08-31
ZA953749B (en) 1996-04-02
EP0682028A1 (fr) 1995-11-15
AU1793395A (en) 1995-11-16
CA2148880A1 (fr) 1995-11-11
NZ272090A (en) 1996-03-26
RU95107154A (ru) 1997-03-20
FI952250A0 (fi) 1995-05-09
PL308516A1 (en) 1995-11-13
NO951812L (no) 1995-11-13
SK59795A3 (en) 1995-12-06
NO951812D0 (no) 1995-05-09
FR2719844B1 (fr) 1996-06-07
FR2719844A1 (fr) 1995-11-17
CN1117970A (zh) 1996-03-06
CZ119695A3 (en) 1995-11-15

Similar Documents

Publication Publication Date Title
EA200401318A1 (ru) Производные хинолинона
ATE226208T1 (de) 4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
CO5251429A1 (es) Derivados de ter-butil-(7-metil-imidazo(1,2-a)piridin-3- il)-amina procedimiento para su preparacion, medicamentos que los contienen, su uso para la preparacion de un medicamento para la inhibicion de la no-sintasa y composiciones farmaceuticas que l
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
DK0657458T3 (da) Inhibitorer af proteinkinase-C
DE69804743D1 (de) Pyrazolo[4,3-d]pyrimidin-Derivate und diese enthaltende pharmazeutische Zubereitungen
KR950031074A (ko) 비-펩티드 타키키닌 수용체 길항물질
CY1112346T1 (el) Ιονιζομενα παραγωγα ινδολινονης και χρηση αυτων ως συνδετhρες ρτκ
KR910002444A (ko) 스피로사이클릭 피페리딘 유도체, 이의 제조방법, 이의 용도 및 이를 함유하는 약학 조성물
CY1108339T1 (el) Παραγωγα spiro(2h-1-benzopyran-2,4´-piperidine) ως αναστολεις της μεταφορας γλυκινης
WO2001094345A3 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
KR950011435A (ko) 이미다졸-4-일 피페리딘 유도체, 이것의 제법 및 이것의 치료에의 이용
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
KR900006330A (ko) 피롤로[3,2-e]피라졸로[1,5-a]피리미딘 유도체 및 이를 함유하는 약제
PT1101770E (pt) Novos derivados de 12,13-(piranosil)-indolo(2,3-a)pirrolo(3,4-c)carbazol e 12,13-(piranosil)-furo(3,4-c)indolo(2,3-a)carbazol processo para a sua preparacao e as composicoes farmaceuticas que os contem
KR950702563A (ko) 테트라시클릭 화합물, 이것의 제조방법 및 중간체와, 항암제로서의 이들의 사용방법(tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents)
KR950032205A (ko) 5,6-디 히드로-4H-티에노 [3,4-c] 피롤유도체, 그것의 제조방법 및 치료에의 이용
ES2075074T3 (es) Acidos 3-fenil-5,6-dihidrobenzo(c)-acridin-7-carboxilicos y compuestos relacionados como agentes quimioterapeuticos para el cancer.
EA200200883A1 (ru) Производные пирано[2,3-с]имидазо[1,2-а]пиридина для лечения заболеваний желудочно-кишечного тракта
EA200300048A1 (ru) Энантиомер 1,2-аннелированного хиназолина, ингибирующий фарнезилтрансферазу
KR970061891A (ko) 신규한 헤테로아릴-옥사졸리디논
HUP9702448A2 (hu) Indolkarbonsavat tartalmazó, parenterálisan adható gyógyászati készítmény
PT99091A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da triazina e da pirimidina, como ingredientes activos, destinadas a reverter a resistencia aos agentes anticancerosos e antimalaricos
PT89000A (pt) Processo para a preparacao de composicoes farmaceuticas e veterinarias analgesicas contendo pirimidinas
EA200000532A3 (ru) НОВЫЕ СОЕДИНЕНИЯ 7-ОКСО-2,3,7,14-ТЕТРАГИДРО-1H-БЕНЗО[b]-ПИРАНО [3,2-h]АКРИДИНКАРБОКСИЛАТА, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19950509

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid